trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['gi ']
6. herb- tdxd in cholangio. p2 data worthy of investigating in p3 but 6% fatal ae due to ild? that s more than rr for some of our drugs! my summary of major gi studies from #asco22 . would love to hear your thoughts. /end 
Personal account. Med Onc. Associate Professor @queensoncology @QueensuPHS. #cancerpolicy #globaloncology #cancergroundshot. Pubs-https://t.co/DE00s50Vpj